EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations
Open Access
- 24 July 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in Virchows Archiv
- Vol. 461 (3), 245-257
- https://doi.org/10.1007/s00428-012-1281-4
Abstract
In non-small cell lung cancer, epidermal growth factor receptor gene mutations and anaplastic lymphoma kinase (ALK) gene rearrangements have a major impact upon the level of response to treatment with specific tyrosine kinase inhibitors. This review describes the molecular basis of ALK inhibition, summarizes current data on the effectiveness and safety of ALK inhibition therapy, describes the different testing methodologies with their advantages and disadvantages, provides a suggested testing algorithm and puts forward a proposal for an external quality assessment program in ALK testing.Keywords
This publication has 68 references indexed in Scilit:
- Mechanisms of Resistance to Crizotinib in Patients with ALK Gene Rearranged Non–Small Cell Lung CancerClinical Cancer Research, 2012
- A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencingGenome Research, 2011
- Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysisThe Lancet Oncology, 2011
- Surrogate markers predicting overall survival for lung cancer: ELCWP recommendationsEuropean Respiratory Journal, 2011
- Increased ALK Gene Copy Number and Amplification are Frequent in Non-small Cell Lung CancerJournal of Thoracic Oncology, 2011
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung CancerNew England Journal of Medicine, 2010
- HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testingVirchows Archiv, 2010
- The biology and treatment of EML4-ALK non-small cell lung cancerEuropean Journal Of Cancer, 2010
- Unique Clinicopathologic Features Characterize ALK-Rearranged Lung Adenocarcinoma in the Western PopulationClinical Cancer Research, 2009
- Long-term preservation of antigenicity on tissue microarraysLaboratory Investigation, 2004